LA Taxpayers Spent $418 Million On Homeless Programs In 2025
Not Clear Whether Vaccines Cause Autism, Needs More Research; NIH Director Says
Russia Vows ‘All Possible Assistance’ To Cuba As US ‘Strangles’ The Population
Who’s Next… What’s Next…?
Will Bombshells Drop At Tuesday’s DC Hearing On Foreign Influence In America’s NGOs
Feds Have Charged 158 Anti-ICE Agitators With Federal Crimes In Minnesota

Democrat Declares Race War

Trump’s Venezuela Tanker Crackdown Goes Global With Indian Ocean Interdiction
Gun Rights Group Slams California Ghost Gun Lawsuit For “Criminalizing Law-Abiding Citizens”
The Inevitable Reversal: When Speculative Narratives Don’t Hold
Lavrov’s Rare Rebuke Of Trump: In Reality, Relations No Better Than Under Biden
Democrat Lawmakers Seek Pentagon Probe Of SpaceX Over Potential China-Linked Investment
China-Linked UNC3886 Targets Singapore Telecom Sector in Cyber Espionage Campaign
Source Texts on ‘Generalplan Ost’ #1: Erhard Wetzel’s 7th February 1942 Letter to the Eastern Ministry
NY Times Columnist Says Vance’s Mother Should Have Sold Him To Feed Her Addiction
Re-Set: Reversing The Debt-Debasement Death-Spiral
China Tells Banks To Limit Exposure To US Treasuries, But To Some This Is “Hardly An Issue At All”
“I Will Not Sit Idly As They Use Me As A Prop”: Is Bill Clinton Moving Back Into Contempt?
Inflation Expectations Tumble To 6-Month Lows, Labor Market Optimism Rebounds; NYFed
Kyndryl Collapses On Accounting Review, CFO Exit As Analysts Brand IBM-Spinoff A “Disaster”
SolarWinds Web Help Desk Exploited for RCE in Multi-Stage Attacks on Exposed Servers
Rabbi Frederick (‘Ephraim’) Karp: Jewish Child Molester
Democrats Flip-Flop On ICE Agents And Body Cameras
Eye On Iran: Pentagon Held Live-Fire War Drills In Persian Gulf
Key Events This Week: Payrolls, CPI And Retail Sales
Green Illusion Suffers Major Setback As Stellantis Takes Massive €22BN EV Write-Down
AOC Announces Training To Teach Agitators How To Block ICE Agents, Doxx Feds
Futures Flat, Erase Overnight Losses As Nervous Traders Brace For Key Week
GLP-1 Feud: HIMS Fires Back At Novo Nordisk, Slams Lawsuit As “Blatant Attack” By Big Pharma